PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 183 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,441,000 | +67.8% | 102,125 | +46.9% | 0.20% | +94.1% |
| Q1 2019 | $2,647,000 | -31.8% | 69,540 | -23.0% | 0.10% | -35.0% |
| Q4 2018 | $3,883,000 | -15.6% | 90,260 | -3.6% | 0.16% | +16.3% |
| Q3 2018 | $4,602,000 | +665.7% | 93,640 | +643.2% | 0.14% | +743.8% |
| Q2 2017 | $601,000 | +188.9% | 12,600 | +486.0% | 0.02% | +220.0% |
| Q3 2014 | $208,000 | -1.4% | 2,150 | -6.5% | 0.01% | -16.7% |
| Q2 2014 | $211,000 | -0.9% | 2,300 | -48.3% | 0.01% | -14.3% |
| Q3 2013 | $213,000 | – | 4,450 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 273,000 | $8,818,000 | 6.24% |
| Standard Investments LLC | 775,388 | $25,045,000 | 4.58% |
| ARMISTICE CAPITAL, LLC | 400,000 | $12,920,000 | 3.06% |
| HealthCor Management, L.P. | 1,575,000 | $50,873,000 | 2.88% |
| DARUMA CAPITAL MANAGEMENT LLC | 1,219,642 | $39,394,000 | 2.24% |
| Consonance Capital Management LP | 631,805 | $20,407,000 | 2.24% |
| Rock Springs Capital Management LP | 713,000 | $23,030,000 | 1.54% |
| Biondo Investment Advisors, LLC | 142,473 | $4,602,000 | 1.52% |
| Opus Point Partners Management, LLC | 50,000 | $1,615,000 | 1.29% |
| Partner Investment Management, L.P. | 26,690 | $862,000 | 1.14% |